Showing 21-30 of 30 results for "".

• Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lines
  https://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/
  Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum to
• Lights, Camera, Botox!
  https://modernaesthetics.com/news/lights-camera-botox/2473185/
  Allergan Aesthetics is hosting an open casting call seeking people who would like to share their BOTOX Cosmetic Story.  Building on the success of the original 
• Call for Entries: Merz Aesthetics Announces First-Ever Innovation Forum
  https://modernaesthetics.com/news/call-for-entries-merz-aesthetics-announces-first-ever-innovation-forum/2473021/
  Merz Aesthetics is launching its first-ever Innovation Forum with a call for abstract submissions seeking the most creative and inventive medical aesthetics abstracts from the next generation of researchers and healthcare professionals.  The author of the winning abstrac
• Galderma, Colorescience to Collaborate on Innovative Skincare
  https://modernaesthetics.com/news/galderma-colorescience-to-collaborate-on-innovative-skincare/2472266/
  Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable aesthetic treatments, the companies have announced. Galderma and
• Tattoo Removal Trends Revealed in Global Analysis of Over 200,000 Individuals
  https://modernaesthetics.com/news/tattoo-removal-trends-revealed-in-global-analysis-of-over-200000-individuals/2475357/
  Key Takeaways Individuals aged 18–39 make up two-thirds of those seeking tattoo removal, with visible areas such as forearms and hands being the most treated. Black ink remains the most commonly removed tattoo pigment. Fitzpatrick Ski
• Allergan Aesthetics Launches Payment Plan Program in Effort to Make Injectables More Affordable
  https://modernaesthetics.com/news/allergan-aesthetics-launches-payment-plan-program-in-effort-to-make-injectables-more-affordable/2473610/
  Patients seeking aesthetic treatments and products now have the option to pay over-time. Allergan Aesthetics, an AbbVie company, launched Alle Payment Plans, powered by Cherry, on Thursday.  Patients can use the payment plan for treatments including Botox and the Juvéde
• Dermatologists Report Uptick in Cosmetic Consults Due to Zoom Dysmorphia
  https://modernaesthetics.com/news/dermatologists-report-uptick-in-cosmetic-consults-due-to-zoom-dysmorphia/2473093/
  During the pandemic, there was a shift to remote work, and demand for video conferencing increased which sired a corresponding rise in the number of patients with negative self-perceptions seeking cosmetic consultations, a new survey shows. In a survey of more than 100 board-certified d
• Avita Therapeutics, Houston Methodist Research Institute Join Forces to Develop New Ways to Rejuvenate Aging Skin
  https://modernaesthetics.com/news/avita-therapeutics-houston-methodist-research-institute-join-forces-to-develop-new-ways-to-rejuvenate-aging-skin/2473017/
  Avita Therapeutics’ is partnering with Houston Methodist Research Institute (HMRI) to identify novel approaches to reverse skin aging and rejuvenate skin with the potential for broader applicability such as scar revision and wound healing.  The project seeks to establish
• Lumenis Virtual Conference 2020 Starts Tomorrow
  https://modernaesthetics.com/news/lumenis-virtual-conference-2020-starts-tomorrow/2472918/
  Those interested in learning more about the latest laser and RF technologies, seeking treatment tips, or looking to network with other practitioners may be interested in the Lumenis Virtual Conference 2020. The conference kicks off Thursday, April 23 and Friday, April 24 with live
• Galderma Set to Start Seven New Clinical Studies
  https://modernaesthetics.com/news/galderma-set-to-start-begin-seven-new-clinical-studies/2472838/
  Galderma is initiating seven clinical studies that seek to support potential, new aesthetic indications including a tear trough indication for Restylane, a facial wrinkles indication for Sculptra Aesthetic as well as several studies supporting an investigational liquid neurotoxin and a Phase 2 st

• Previous
• 1
• 2
• 3
• Next